As of 2025-12-15, the Relative Valuation of FibroGen Inc (FGEN) is 1,405.74 USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.38 USD, the upside of FibroGen Inc based on Relative Valuation is 16675.0%.
The range of the Relative Valuation is 1,141.64 - 1,650.68 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.4x - 26.0x | 24.4x |
| Forward P/E multiples | 23.9x - 31.0x | 28.4x |
| Fair Price | 1,141.64 - 1,650.68 | 1,405.74 |
| Upside | 13523.3% - 19597.9% | 16675.0% |
| Date | P/E |
| 2025-12-12 | 0.16 |
| 2025-12-11 | 0.16 |
| 2025-12-10 | 0.17 |
| 2025-12-09 | 0.16 |
| 2025-12-08 | 0.16 |
| 2025-12-05 | 0.16 |
| 2025-12-04 | 0.15 |
| 2025-12-03 | 0.15 |
| 2025-12-02 | 0.15 |
| 2025-12-01 | 0.16 |
| 2025-11-28 | 0.17 |
| 2025-11-26 | 0.17 |
| 2025-11-25 | 0.16 |
| 2025-11-24 | 0.16 |
| 2025-11-21 | 0.16 |
| 2025-11-20 | 0.16 |
| 2025-11-19 | 0.16 |
| 2025-11-18 | 0.16 |
| 2025-11-17 | 0.16 |
| 2025-11-14 | 0.16 |
| 2025-11-13 | 0.17 |
| 2025-11-12 | 0.17 |
| 2025-11-11 | 0.19 |
| 2025-11-10 | 0.21 |
| 2025-11-07 | 0.21 |
| 2025-11-06 | 0.21 |
| 2025-11-05 | 0.21 |
| 2025-11-04 | 0.21 |
| 2025-11-03 | 0.21 |
| 2025-10-31 | 0.21 |
| 2025-10-30 | 0.21 |
| 2025-10-29 | 0.20 |
| 2025-10-28 | 0.20 |
| 2025-10-27 | 0.21 |
| 2025-10-24 | 0.20 |
| 2025-10-23 | 0.20 |
| 2025-10-22 | 0.21 |
| 2025-10-21 | 0.21 |
| 2025-10-20 | 0.21 |
| 2025-10-17 | 0.19 |
| 2025-10-16 | 0.20 |
| 2025-10-15 | 0.21 |
| 2025-10-14 | 0.21 |
| 2025-10-13 | 0.21 |
| 2025-10-10 | 0.20 |
| 2025-10-09 | 0.21 |
| 2025-10-08 | 0.21 |
| 2025-10-07 | 0.21 |
| 2025-10-06 | 0.21 |
| 2025-10-03 | 0.22 |